Group 1 - The core viewpoint of the article highlights the performance of fund manager Tan Donghan, who manages a total of 9 funds, with the best-performing fund being ICBC Vanguard Three-Year Holding Mixed Fund (018446), which experienced a net value decline of 5.02% in the latest quarter [1] - During Tan Donghan's tenure as the manager of ICBC Medical Health Stock A (006002), the cumulative return reached 177.8%, with an average annualized return of 14.62% [1] - The number of adjustments made to the heavy-weight stocks during this period was 58, with a profit rate of 62.07%, resulting in 36 profitable adjustments and 7 instances of doubling returns, with a total doubling rate of 12.07% [1] Group 2 - Example of a doubling case with Yingke Medical (300677): The fund bought shares in Q1 2020 and sold them in Q1 2021, achieving an estimated return of 812.18%, while Yingke Medical's annual revenue growth from 2020 to 2021 was 17.37% [2] - Example of an adjustment case with Boteng Co., Ltd. (300363): The fund purchased shares in Q1 2021 and sold them in Q1 2022, resulting in an estimated return of 94.05%, with Boteng's net profit growth from 2021 to 2022 reaching 282.78% [3] - Example of a loss case with Kailaiying (002821): The fund bought shares in Q4 2021 and sold them in Q2 2024, incurring an estimated return of -73.42%, despite Kailaiying's revenue growth from 2021 to 2024 being 25.13% [4]

Core Viewpoint - Sanxin Medical reported a net profit of 227 million yuan for 2024, reflecting a year-on-year growth of 9.66% [1] Financial Data and Indicators - Basic earnings per share increased to 0.4416 yuan, up 10.76% from 0.3987 yuan in 2023 [2] - Operating revenue reached 1.5 billion yuan, a 15.38% increase from 1.3 billion yuan in 2023 [2] - Net profit for the year was 227 million yuan, compared to 207 million yuan in 2023, marking a 9.66% increase [2] - Return on equity slightly decreased to 17.81% from 18.02% in the previous year [2] - The net asset per share was reported as 0, indicating a 100% decrease from 2.4 yuan in 2023 [2] Shareholder Structure - The top ten unrestricted shareholders collectively hold 95.6494 million shares, accounting for 26.84% of the circulating shares, with an increase of 8.7924 million shares compared to the previous period [2] - Notable shareholders include Peng Yixing with 32.2315 million shares (9.04%) and Wan Xiaoping with 16.9549 million shares (4.76%) [3] - New entrants among the top shareholders include Hai Life Insurance with 8.4447 million shares (2.37%) and another Hai Life Insurance product with 5.7763 million shares (1.62%) [3] Dividend Distribution - The company announced a dividend distribution plan of 2 yuan per share (including tax) [5]